A self-assembling prodrug nanosystem to enhance metabolic stability and anticancer activity of gemcitabine
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A self-assembling prodrug nanosystem to enhance metabolic stability and anticancer activity of gemcitabine
Authors
Keywords
Self-assembling prodrug, Gemcitabine, Amphiphilic dendrimer, Anticancer candidate, Nanomicelles
Journal
CHINESE CHEMICAL LETTERS
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2021-12-03
DOI
10.1016/j.cclet.2021.11.083
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Stimulus-responsive liposomes for biomedical applications
- (2021) Antonia I. Antoniou et al. DRUG DISCOVERY TODAY
- Nanoparticulation of Prodrug into Medicines for Cancer Therapy
- (2021) Yuezhou Zhang et al. Advanced Science
- Pancreatic cancer
- (2020) Jonathan D Mizrahi et al. LANCET
- Self-Assembling Supramolecular Dendrimers for Biomedical Applications: Lessons Learned from Poly(amidoamine) Dendrimers
- (2020) Zhenbin Lyu et al. ACCOUNTS OF CHEMICAL RESEARCH
- Toward a Molecular Basis of Cellular Nucleoside Transport in Humans
- (2020) Nicholas J. Wright et al. CHEMICAL REVIEWS
- Recent advances and prospects in gemcitabine drug delivery systems
- (2020) Shweta Paroha et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Rational design of a minimalist nanoplatform to maximize immunotherapeutic efficacy: Four birds with one stone
- (2020) Shiyao Zhou et al. JOURNAL OF CONTROLLED RELEASE
- Engineering precision nanoparticles for drug delivery
- (2020) Michael J. Mitchell et al. NATURE REVIEWS DRUG DISCOVERY
- Cathepsin-sensitive nanoscale drug delivery systems for cancer therapy and other diseases
- (2019) Divya Dheer et al. ADVANCED DRUG DELIVERY REVIEWS
- Tumor-specific delivery of gemcitabine with activatable liposomes
- (2019) Samantha T. Tucci et al. JOURNAL OF CONTROLLED RELEASE
- Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
- (2019) Yuan Zhang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Smart cancer nanomedicine
- (2019) Roy van der Meel et al. Nature Nanotechnology
- Self-Assembled Gemcitabine Prodrug Nanoparticles Show Enhanced Efficacy against Patient-Derived Pancreatic Ductal Adenocarcinoma
- (2019) Liming Wu et al. ACS Applied Materials & Interfaces
- Stereocomplex Prodrugs of Oligo(lactic acid)n-Gemcitabine in Poly(ethylene glycol)-block-poly(d,l-lactic acid) Micelles for Improved Physical Stability and Enhanced Antitumor Efficacy
- (2018) Yu Tong Tam et al. ACS Nano
- Precision design of nanomedicines to restore gemcitabine chemosensitivity for personalized pancreatic ductal adenocarcinoma treatment
- (2018) Xiao Zhao et al. BIOMATERIALS
- Negative dendritic effect on enzymatic hydrolysis of dendrimer conjugates
- (2018) Zhengwei Zhou et al. CHEMICAL COMMUNICATIONS
- Gemcitabine-vitamin E conjugates: Synthesis, characterization, entrapment into nanoemulsions, and in-vitro deamination and antitumor activity
- (2017) Ahmed Abu-Fayyad et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Conjugation of squalene to gemcitabine as unique approach exploiting endogenous lipoproteins for drug delivery
- (2017) Dunja Sobot et al. Nature Communications
- Integrin-Targeting Knottin Peptide-Drug Conjugates Are Potent Inhibitors of Tumor Cell Proliferation
- (2016) Nick Cox et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Self-Delivery Nanoparticles of Amphiphilic Methotrexate-Gemcitabine Prodrug for Synergistic Combination Chemotherapy via Effect of Deoxyribonucleotide Pools
- (2016) Yao Wang et al. BIOCONJUGATE CHEMISTRY
- Supramolecular biomaterials
- (2016) Matthew J. Webber et al. NATURE MATERIALS
- Mastering Dendrimer Self-Assembly for Efficient siRNA Delivery: From Conceptual Design to In Vivo Efficient Gene Silencing
- (2016) Chao Chen et al. Small
- Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial
- (2015) Nick Thatcher et al. LANCET ONCOLOGY
- Anticancer drug nanomicelles formed by self-assembling amphiphilic dendrimer to combat cancer drug resistance
- (2015) Tuo Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combination of Small Molecule Prodrug and Nanodrug Delivery: Amphiphilic Drug–Drug Conjugate for Cancer Therapy
- (2014) Ping Huang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Theranostic Nanoparticles with Controlled Release of Gemcitabine for Targeted Therapy and MRI of Pancreatic Cancer
- (2013) Gee Young Lee et al. ACS Nano
- Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer
- (2013) Helmut Oettle et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Gemcitabine-loaded albumin nanospheres (GEM-ANPs) inhibit PANC-1 cells in vitro and in vivo
- (2013) Ji Li et al. Nanoscale Research Letters
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now